Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Circ Cardiovasc Interv. 2008 Oct;1(2):119-25. doi: 10.1161/CIRCINTERVENTIONS.108.772350. Epub 2008 Sep 3.
Patients with chronic cervical internal carotid artery occlusion (ICAO) and cerebral ischemia may benefit from revascularization. The feasibility of endovascular recanalization for chronic ICAO has been reported recently, but its safety is still unproven. We report the follow-up results of 54 chronic ICAO patients who underwent endovascular recanalization, focusing on potential vascular complications and corresponding management.
Endovascular recanalization for chronic ICAO was attempted in 54 consecutive patients (48 men; 69.2 + or - 9.8 years old) with either recurrent neurological deficit or objective ipsilateral hemisphere ischemia. Mean duration from occlusion documentation to the procedure was 237 + or - 327 days (range, 56 to 1424 days). Adverse events while in the hospital and during the 3-month follow-up were recorded. Successful recanalization was achieved in 35 of 54 patients (65%). Three-month cumulative stroke and death rate was 4% (2 of 54), including 1 in-hospital fatal nonipsilateral stroke and 1 in-hospital minor ipsilateral stroke secondary to systemic hypotension. Vascular complications developed in 3 of 54 patients (6%), including 1 late pseudoaneurysm formation 3 months after recanalization, 1 immediate carotid-cavernous fistula after recanalization, and 1 minor extravasation at carotid bifurcation after failed recanalization. However, no clinical sequela was noted with close follow-up and adequate management.
Certain immediate or delayed vascular complications may develop during or after the endovascular recanalization for chronic ICAO. Although periprocedural death and stroke rate is limited in our study, further study combining neuroimaging tools and cognitive function evaluation is mandatory to assess its utility and appropriateness in patients with chronic ICAO.
患有慢性颈内动脉闭塞(ICAO)和脑缺血的患者可能受益于血运重建。最近有报道称,慢性 ICAO 的血管内再通是可行的,但安全性仍未得到证实。我们报告了 54 例接受血管内再通的慢性 ICAO 患者的随访结果,重点关注潜在的血管并发症及其相应的处理。
连续 54 例(48 例男性;69.2±9.8 岁)因复发性神经功能缺损或同侧半球缺血客观证据而行慢性 ICAO 血管内再通。从闭塞记录到手术的平均时间为 237±327 天(范围为 56~1424 天)。记录住院期间和 3 个月随访期间的不良事件。
54 例患者中有 35 例(65%)成功再通。3 个月累积卒中率和死亡率为 4%(2/54),包括 1 例住院期间非同侧致命性卒中,1 例因全身低血压引起的住院期间同侧轻微卒中。54 例患者中有 3 例(6%)发生血管并发症,包括 1 例再通后 3 个月出现迟发性假性动脉瘤形成,1 例再通后立即出现颈动脉海绵窦瘘,1 例再通失败后颈动脉分叉处轻微外渗。然而,通过密切随访和充分管理,没有发现临床后遗症。
在慢性 ICAO 的血管内再通过程中或之后,可能会出现某些即刻或迟发性血管并发症。尽管在我们的研究中,围手术期死亡和卒中发生率有限,但需要进一步结合神经影像学工具和认知功能评估的研究,以评估其在慢性 ICAO 患者中的效用和适宜性。